Rapid Micro Biosystems (RPID) Total Non-Current Liabilities (2020 - 2026)

Rapid Micro Biosystems has reported Total Non-Current Liabilities for 7 years, with the latest figure at $41.6 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 111.97% year-over-year to $41.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.6 million (up 111.97% YoY) and the FY2025 annual result came in at $41.2 million, up 80.78% from the prior year.
• Total Non-Current Liabilities grew to $41.6 million in Q1 2026 per RPID's latest filing, from $41.2 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $41.6 million in Q1 2026 and troughed at $19.6 million in Q1 2025.
• A 5-year average of $25.4 million and a median of $22.2 million in 2024 frame the typical range for Total Non-Current Liabilities.
• The widest YoY moves for Total Non-Current Liabilities: up 242.93% in 2022, down 51.63% in 2022.
• Over 5 years, Total Non-Current Liabilities stood at $26.3 million in 2022, then dropped by 4.01% to $25.2 million in 2023, then dropped by 9.46% to $22.8 million in 2024, then jumped by 80.78% to $41.2 million in 2025, then gained by 0.91% to $41.6 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $41.6 million, $41.2 million, and $39.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.